A protocol for developing, disseminating, and implementing a core outcome set for pre-eclampsia

James M N Duffy, Janneke van ‘t Hooft, Chris Gale, Mark Brown, William Grobman, Ray Fitzpatrick, S. Ananth Karumanchi, Nuala Lucas, Laura Magee, Ben Mol, Michael Stark, Shakila Thangaratinam, Mathew Wilson, Peter von Dadelszen, Paula Williamson, Khalid S. Khan, Sue Ziebland, Richard J. McManus

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background Pre-eclampsia is a serious complication of pregnancy and contributes to maternal and offspring mortality and morbidity. Randomised controlled trials evaluating therapeutic interventions for pre-eclampsia have reported many different outcomes and outcome measures. Such variation contributes to an inability to compare, contrast, and combine individual studies, limiting the usefulness of research to inform clinical practice. The development and use of a core outcome set would help to address these issues ensuring outcomes important to all stakeholders, including patients, will be collected and reported in a standardised fashion. Methods An international steering group including healthcare professionals, researchers, and patients, has been formed to guide the development of this core outcome set. Potential outcomes will be identified through a comprehensive literature review and semi-structured interviews with patients. Potential core outcomes will be entered into an international, multi-perspective online Delphi survey. All key stakeholders, including healthcare professionals, researchers, and patients will be invited to participate. The modified Delphi method encourages whole and stakeholder group convergence towards consensus ‘core’ outcomes. Once core outcomes have been agreed upon it is important to determine how they should be measured. The truth, discrimination, and feasibility assessment framework will assess the quality of potential outcome measures. High quality outcome measures will be associated with core outcomes. Mechanisms exist to disseminate and implement the resulting core outcome set within an international context. Discussion Embedding the core outcome set within future clinical trials, systematic reviews, and clinical practice guidelines could make a profound contribution to advancing the usefulness of research to inform clinical practice, enhance patient care, and improve maternal and offspring outcomes. The infrastructure created by developing a core outcome set for pre-eclampsia could be leveraged in other settings, for example selecting research priorities and clinical practice guideline development. Prospective registration [1] Core Outcome Measures in Effectiveness Trials (COMET) registration number: 588. [2] International Prospective Register of Systematic Reviews (PROSPERO) registration number: CRD42015015529.

LanguageEnglish
Pages274-278
Number of pages5
JournalPregnancy Hypertension
Volume6
Issue number4
DOIs
Publication statusPublished - 1 Oct 2016

Keywords

  • Core outcome set
  • Modified Delphi method
  • Pre-eclampsia
  • Semi-structured interviews
  • Systematic review

ASJC Scopus subject areas

  • Internal Medicine
  • Obstetrics and Gynaecology

Cite this

Duffy, J. M. N., van ‘t Hooft, J., Gale, C., Brown, M., Grobman, W., Fitzpatrick, R., ... McManus, R. J. (2016). A protocol for developing, disseminating, and implementing a core outcome set for pre-eclampsia. Pregnancy Hypertension, 6(4), 274-278. https://doi.org/10.1016/j.preghy.2016.04.008
Duffy, James M N ; van ‘t Hooft, Janneke ; Gale, Chris ; Brown, Mark ; Grobman, William ; Fitzpatrick, Ray ; Karumanchi, S. Ananth ; Lucas, Nuala ; Magee, Laura ; Mol, Ben ; Stark, Michael ; Thangaratinam, Shakila ; Wilson, Mathew ; von Dadelszen, Peter ; Williamson, Paula ; Khan, Khalid S. ; Ziebland, Sue ; McManus, Richard J. / A protocol for developing, disseminating, and implementing a core outcome set for pre-eclampsia. In: Pregnancy Hypertension. 2016 ; Vol. 6, No. 4. pp. 274-278.
@article{14d79282dc614694a1e046a8b05c22b7,
title = "A protocol for developing, disseminating, and implementing a core outcome set for pre-eclampsia",
abstract = "Background Pre-eclampsia is a serious complication of pregnancy and contributes to maternal and offspring mortality and morbidity. Randomised controlled trials evaluating therapeutic interventions for pre-eclampsia have reported many different outcomes and outcome measures. Such variation contributes to an inability to compare, contrast, and combine individual studies, limiting the usefulness of research to inform clinical practice. The development and use of a core outcome set would help to address these issues ensuring outcomes important to all stakeholders, including patients, will be collected and reported in a standardised fashion. Methods An international steering group including healthcare professionals, researchers, and patients, has been formed to guide the development of this core outcome set. Potential outcomes will be identified through a comprehensive literature review and semi-structured interviews with patients. Potential core outcomes will be entered into an international, multi-perspective online Delphi survey. All key stakeholders, including healthcare professionals, researchers, and patients will be invited to participate. The modified Delphi method encourages whole and stakeholder group convergence towards consensus ‘core’ outcomes. Once core outcomes have been agreed upon it is important to determine how they should be measured. The truth, discrimination, and feasibility assessment framework will assess the quality of potential outcome measures. High quality outcome measures will be associated with core outcomes. Mechanisms exist to disseminate and implement the resulting core outcome set within an international context. Discussion Embedding the core outcome set within future clinical trials, systematic reviews, and clinical practice guidelines could make a profound contribution to advancing the usefulness of research to inform clinical practice, enhance patient care, and improve maternal and offspring outcomes. The infrastructure created by developing a core outcome set for pre-eclampsia could be leveraged in other settings, for example selecting research priorities and clinical practice guideline development. Prospective registration [1] Core Outcome Measures in Effectiveness Trials (COMET) registration number: 588. [2] International Prospective Register of Systematic Reviews (PROSPERO) registration number: CRD42015015529.",
keywords = "Core outcome set, Modified Delphi method, Pre-eclampsia, Semi-structured interviews, Systematic review",
author = "Duffy, {James M N} and {van ‘t Hooft}, Janneke and Chris Gale and Mark Brown and William Grobman and Ray Fitzpatrick and Karumanchi, {S. Ananth} and Nuala Lucas and Laura Magee and Ben Mol and Michael Stark and Shakila Thangaratinam and Mathew Wilson and {von Dadelszen}, Peter and Paula Williamson and Khan, {Khalid S.} and Sue Ziebland and McManus, {Richard J.}",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.preghy.2016.04.008",
language = "English",
volume = "6",
pages = "274--278",
journal = "Pregnancy Hypertension",
issn = "2210-7789",
publisher = "Elsevier BV",
number = "4",

}

Duffy, JMN, van ‘t Hooft, J, Gale, C, Brown, M, Grobman, W, Fitzpatrick, R, Karumanchi, SA, Lucas, N, Magee, L, Mol, B, Stark, M, Thangaratinam, S, Wilson, M, von Dadelszen, P, Williamson, P, Khan, KS, Ziebland, S & McManus, RJ 2016, 'A protocol for developing, disseminating, and implementing a core outcome set for pre-eclampsia', Pregnancy Hypertension, vol. 6, no. 4, pp. 274-278. https://doi.org/10.1016/j.preghy.2016.04.008

A protocol for developing, disseminating, and implementing a core outcome set for pre-eclampsia. / Duffy, James M N; van ‘t Hooft, Janneke; Gale, Chris; Brown, Mark; Grobman, William; Fitzpatrick, Ray; Karumanchi, S. Ananth; Lucas, Nuala; Magee, Laura; Mol, Ben; Stark, Michael; Thangaratinam, Shakila; Wilson, Mathew; von Dadelszen, Peter; Williamson, Paula; Khan, Khalid S.; Ziebland, Sue; McManus, Richard J.

In: Pregnancy Hypertension, Vol. 6, No. 4, 01.10.2016, p. 274-278.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A protocol for developing, disseminating, and implementing a core outcome set for pre-eclampsia

AU - Duffy, James M N

AU - van ‘t Hooft, Janneke

AU - Gale, Chris

AU - Brown, Mark

AU - Grobman, William

AU - Fitzpatrick, Ray

AU - Karumanchi, S. Ananth

AU - Lucas, Nuala

AU - Magee, Laura

AU - Mol, Ben

AU - Stark, Michael

AU - Thangaratinam, Shakila

AU - Wilson, Mathew

AU - von Dadelszen, Peter

AU - Williamson, Paula

AU - Khan, Khalid S.

AU - Ziebland, Sue

AU - McManus, Richard J.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Background Pre-eclampsia is a serious complication of pregnancy and contributes to maternal and offspring mortality and morbidity. Randomised controlled trials evaluating therapeutic interventions for pre-eclampsia have reported many different outcomes and outcome measures. Such variation contributes to an inability to compare, contrast, and combine individual studies, limiting the usefulness of research to inform clinical practice. The development and use of a core outcome set would help to address these issues ensuring outcomes important to all stakeholders, including patients, will be collected and reported in a standardised fashion. Methods An international steering group including healthcare professionals, researchers, and patients, has been formed to guide the development of this core outcome set. Potential outcomes will be identified through a comprehensive literature review and semi-structured interviews with patients. Potential core outcomes will be entered into an international, multi-perspective online Delphi survey. All key stakeholders, including healthcare professionals, researchers, and patients will be invited to participate. The modified Delphi method encourages whole and stakeholder group convergence towards consensus ‘core’ outcomes. Once core outcomes have been agreed upon it is important to determine how they should be measured. The truth, discrimination, and feasibility assessment framework will assess the quality of potential outcome measures. High quality outcome measures will be associated with core outcomes. Mechanisms exist to disseminate and implement the resulting core outcome set within an international context. Discussion Embedding the core outcome set within future clinical trials, systematic reviews, and clinical practice guidelines could make a profound contribution to advancing the usefulness of research to inform clinical practice, enhance patient care, and improve maternal and offspring outcomes. The infrastructure created by developing a core outcome set for pre-eclampsia could be leveraged in other settings, for example selecting research priorities and clinical practice guideline development. Prospective registration [1] Core Outcome Measures in Effectiveness Trials (COMET) registration number: 588. [2] International Prospective Register of Systematic Reviews (PROSPERO) registration number: CRD42015015529.

AB - Background Pre-eclampsia is a serious complication of pregnancy and contributes to maternal and offspring mortality and morbidity. Randomised controlled trials evaluating therapeutic interventions for pre-eclampsia have reported many different outcomes and outcome measures. Such variation contributes to an inability to compare, contrast, and combine individual studies, limiting the usefulness of research to inform clinical practice. The development and use of a core outcome set would help to address these issues ensuring outcomes important to all stakeholders, including patients, will be collected and reported in a standardised fashion. Methods An international steering group including healthcare professionals, researchers, and patients, has been formed to guide the development of this core outcome set. Potential outcomes will be identified through a comprehensive literature review and semi-structured interviews with patients. Potential core outcomes will be entered into an international, multi-perspective online Delphi survey. All key stakeholders, including healthcare professionals, researchers, and patients will be invited to participate. The modified Delphi method encourages whole and stakeholder group convergence towards consensus ‘core’ outcomes. Once core outcomes have been agreed upon it is important to determine how they should be measured. The truth, discrimination, and feasibility assessment framework will assess the quality of potential outcome measures. High quality outcome measures will be associated with core outcomes. Mechanisms exist to disseminate and implement the resulting core outcome set within an international context. Discussion Embedding the core outcome set within future clinical trials, systematic reviews, and clinical practice guidelines could make a profound contribution to advancing the usefulness of research to inform clinical practice, enhance patient care, and improve maternal and offspring outcomes. The infrastructure created by developing a core outcome set for pre-eclampsia could be leveraged in other settings, for example selecting research priorities and clinical practice guideline development. Prospective registration [1] Core Outcome Measures in Effectiveness Trials (COMET) registration number: 588. [2] International Prospective Register of Systematic Reviews (PROSPERO) registration number: CRD42015015529.

KW - Core outcome set

KW - Modified Delphi method

KW - Pre-eclampsia

KW - Semi-structured interviews

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=84971280210&partnerID=8YFLogxK

U2 - 10.1016/j.preghy.2016.04.008

DO - 10.1016/j.preghy.2016.04.008

M3 - Article

VL - 6

SP - 274

EP - 278

JO - Pregnancy Hypertension

T2 - Pregnancy Hypertension

JF - Pregnancy Hypertension

SN - 2210-7789

IS - 4

ER -